Pharma Journalist -

AstraZeneca announced a new collaboration with Cancer Research UK to launch a centre of excellence in genetic screening, cancer modelling and big data processing aimed at accelerating…
Read More...

Bristol-Myers Squibb Company and Vedanta Biosciences announced a clinical trial collaboration to evaluate Bristol-Myers Squibb's programmed death-1 (PD-1) immune checkpoint inhibitor…
Read More...

Pharmaceutical Product Development, LLC (PPD) is adding gene and cell therapy analytical testing to its GMP (good manufacturing practices) laboratory in Athlone, Ireland, to support the…
Read More...

Merck KGaA, Darmstadt, Germany announced that it has entered into a licensing agreement with Cyclica Inc. for the use of Ligand Express, a cloud-based in silico proteome screening…
Read More...

PAREXEL announced a new collaboration with Eli Lilly and Company to launch a clinical research learning and development program in China. The program will bring high-value training…
Read More...

Mylan announced the U.S. launch of Lansoprazole Delayed-Release (DR) Orally Disintegrating Tablets (ODT), 15 mg and 30 mg, a generic version of Takeda's Prevacid® SoluTab DR ODT. Mylan…
Read More...

Roche announced that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq…
Read More...

AbbVie announced the decision to stop enrollment for the TAHOE trial, a Phase 3 study evaluating Rovalpituzumab Tesirine (Rova-T) as a second-line therapy for advanced small-cell lung…
Read More...

SMi presents the return of the 11th annual Social Media in the Pharmaceutical Industry conference taking place in London, UK on the 21st - 22nd January 2019. The event brings in voices…
Read More...

SMi Reports: This year’s RNA Therapeutics Conference Chair Ekkehard Leberer, Senior Director at Sanofi-Aventis Deutschland GmbH, has released a letter of invitation detailing next…
Read More...